1.35%| Prev Close: | 12.87 |
|---|---|
| Open: | N/A |
| Bid: | 8.50 x 200 |
| Ask: | 13.36 x 500 |
| 1y Target Est: | 15.50 |
| Beta: | 1.84 |
| Next Earnings Date: | N/A |
| Day's Range: | N/A - N/A |
|---|---|
| 52wk Range: | 8.25 - 13.47 |
| Volume: | 0 |
| Avg Vol (3m): | 123,381 |
| Market Cap: | 352.55M |
| P/E (ttm): | 16.91 |
| EPS (ttm): | 0.76 |
| Div & Yield: | 0.22 (1.70%) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- ACETO Names Satish Srinivasan as Rising Pharmaceuticals' President and COOGlobeNewswire(Thu, Jun 13)
- ACETO Subsidiary, Rising Pharmaceuticals, to Launch the Authorized Generic Version of Covis Pharma S.a.r.l.'s Rilutek(R)GlobeNewswire(Tue, Jun 11)
- Aceto About To Put More Money In Your Pocket (ACET)at Forbes(Mon, Jun 10)
- ACETO Subsidiary, Rising Pharmaceuticals, Launches Generic Version of Nasalide(R)GlobeNewswire(Tue, Jun 4)
- 1 Tech, 1 Basic Materials And 1 Services Company With Recent Intensive Insider Sellingat Seeking Alpha(Wed, May 29)
- ACETO to Present at the Jefferies 2013 Global Healthcare ConferenceGlobeNewswire(Tue, May 28)
- Interesting ACET Put And Call For Julyat TheStreet(Mon, May 20)
- ACETO CORP FinancialsEDGAR Online Financials(Fri, May 17)
- This Undervalued Dividend Stock Just Announced Record Earningsat Seeking Alpha(Sat, May 11)
- Aceto Beats on Both Top and Bottom Linesat Motley Fool(Fri, May 10)
- Aceto Management Discusses Q3 2013 Results - Earnings Call Transcriptat Seeking Alpha(Fri, May 10)
- Aceto Q3 2013 Earnings Call scheduled for 9:00 am ET todayCCBN(Fri, May 10)
- ACETO CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online(Fri, May 10)
- ACETO Board of Directors Declares Quarterly Cash DividendGlobeNewswire(Thu, May 9)
- ACETO Reports Record Fiscal 2013 Third Quarter Net Sales and Gross ProfitGlobeNewswire(Thu, May 9)
Press Releases
- ACETO Names Satish Srinivasan as Rising Pharmaceuticals' President and COOGlobeNewswire(Thu, Jun 13)
- ACETO Subsidiary, Rising Pharmaceuticals, to Launch the Authorized Generic Version of Covis Pharma S.a.r.l.'s Rilutek(R)GlobeNewswire(Tue, Jun 11)
- ACETO Subsidiary, Rising Pharmaceuticals, Launches Generic Version of Nasalide(R)GlobeNewswire(Tue, Jun 4)
Reports
- ValuEngine Industry Report for Chemicals-diversifiedValuEngine, Inc.(Jun 20)
- ACET: Due Diligence Review: Forensic Earnings and ValuationNew Constructs, LLC(Jun 19)
- ACET - Aceto Corp - Upgraded to a Buy - Company Analysis and ASR Ranking ReportAlpha Street Research(Jun 18)